Condition
Drug-Drug Interactions
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (2)
Trial Status
Unknown2
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07426042Phase 1Not Yet RecruitingPrimary
Effect of Dexamethasone on CYP Enzyme Activity in Healthy Male Subjects
NCT04710615Not ApplicableUnknownPrimary
Impact of an Artificial Intelligence Platform on Inappropriate Medication Use in Older Adults
NCT03411122Phase 1CompletedPrimary
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Drug Interaction Potential of Napabucasin in Healthy Volunteers
NCT03370523Unknown
Epidemiology of Polipharmacy and Potential Drug-Drug Interactions in Elderly Cardiac Outpatients
NCT03581994Not ApplicableCompletedPrimary
DDI Effectiveness and Clinical Awareness
Showing all 5 trials